Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jianping Hu

1PUBLICATIONS
5CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Aug 30, 2022
The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells.

Alison M Kurimchak, Carlos Herrera-Montávez, Sara Montserrat-Sangrà

Pageof 1

Frequent Collaborators

1 joint publications

Alison M Kurimchak

1 joint publications

Daniela Araiza-Olivera

1 joint publications

Alfonso Bellacosa

1 joint publications

Jian Jin

1 joint publications

James S Duncan

Frequent Collaborators

1 joint publications

Alison M Kurimchak

1 joint publications

Daniela Araiza-Olivera

1 joint publications

Alfonso Bellacosa

1 joint publications

Jian Jin

Top Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

13.5K
See more related videos

Top Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

13.5K
See more related videos